The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Current Diagnosis and Management of Small-Cell Lung Cancer
Open accessAbstract
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characteristics from non-small-cell lung cancer. SCLC has high metastatic potential, resulting in a clinically poor prognosis. Early concurrent chemo-radiation is the standard of care for limited-stage SCLC (LS-SCLC). Prophylactic cranial irradiation (PCI) is recommended for patients with LS-SCLC without progression of disease after initial therapy. A combination of etoposide and cisplatin or carboplatin remains the mainstay of first-line treatment for ES-SCLC, with the addition of atezolizumab, now becoming standard. Most SCLCs initially respond to therapy but almost invariably recur. Topotecan and amrubicin (in Japan) remain the primary chemotherapy options for relapsed SCLC. Immunotherapy, including nivolumab with or without ipilimumab, is now available for refractory disease. In general, the poor prognosis of SCLC has not improved significantly for more than 3 decades. Recently, next-generation molecular profiling studies have identified new therapeutic targets for SCLC. A variety of proapoptotic agents, compounds capitalizing on DNA-repair defects, immunotherapy agents, and antibody-drug conjugates are being evaluated in SCLC, with a number of them showing early promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Goldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W. E. E., Nicholson, A. G., Groome, P., Mitchell, A., Bolejack, V., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.009 · Cited by 4,607
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer
Horn, L., Mansfield, A. S., Szczęsna, A., Havel, L., Krzakowski, M., Hochmair, M. J., Huemer, F., Losonczy, G., Johnson, M. L., Nishio, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809064 · Cited by 3,586
Self-citationComprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
Aupérin, A., Arriagada, R., Pignon, J.-P., Le Péchoux, C., Gregor, A., Stephens, R. J., Kristjansen, P. E. G., Johnson, B. E., Ueoka, H., Wagner, H., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410703 · Cited by 1,718
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., & Johnson, D. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400403 · Cited by 1,506
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,397
Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
Pignon, J.-P., Arriagada, R., Ihde, D. C., Johnson, D. H., Perry, M. C., Souhami, R. L., Brodin, O., Joss, R. A., Kies, M. S., Lebeau, B., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272302 · Cited by 1,331
Antonia, S. J., López-Martin, J. A., Bendell, J., Ott, P. A., Taylor, M., Eder, J. P., Jäger, D., Pietanza, M. C., Le, D. T., de Braud, F., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30098-5 · Cited by 1,244
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., Postmus, P., Collette, L., Musat, E., & Senan, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071780 · Cited by 1,133
von Pawel, J., Schiller, J. H., Shepherd, F. A., Fields, S. Z., Kleisbauer, J. P., Chrysson, N. G., Stewart, D. J., Clark, P. I., Palmer, M. C., Depierre, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.658 · Cited by 968
Brown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 958
The Syndrome of Inappropriate Antidiuresis
Ellison, D. H., & Berl, T. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp066837 · Cited by 945
Hellmann, M. D., Callahan, M. K., Awad, M. M., Calvo, E., Ascierto, P. A., Atmaca, A., Rizvi, N. A., Hirsch, F. R., Selvaggi, G., Szustakowski, J. D., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.001 · Cited by 893
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836
Warde, P., & Payne, D. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.890 · Cited by 816
Devesa, S. S., Bray, F., Vizcaino, A. P., & Parkin, D. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21183 · Cited by 745
O'Brien, M. E. R., Ciuleanu, T.-E., Tsekov, H., Shparyk, Y., Čučeviá, B., Juhasz, G., Thatcher, N., Ross, G. A., Dane, G. C., & Crofts, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5821 · Cited by 649
Small cell lung cancer: Where do we go from here?
Byers, L. A., & Rudin, C. M. (2015) · Cancer · doi:10.1002/cncr.29098 · Cited by 636
Früh, M., De Ruysscher, D., Popat, S., Crinò, L., Peters, S., & Felip, E. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt178 · Cited by 613
Slotman, B. J., van Tinteren, H., Praag, J. O., Knegjens, J. L., El Sharouni, S. Y., Hatton, M., Keijser, A., Faivre-Finn, C., & Senan, S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61085-0 · Cited by 604
Faivre-Finn, C., Snee, M., Ashcroft, L., Appel, W., Barlesi, F., Bhatnagar, A., Bezjak, A., Cardenal, F., Fournel, P., Harden, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30318-2 · Cited by 592
Rudin, C. M., Pietanza, M. C., Bauer, T. M., Ready, N., Morgensztern, D., Glisson, B. S., Byers, L. A., Johnson, M. L., Burris, H. A., Robert, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30565-4 · Cited by 574
Rudin, C. M., Hann, C. L., Garon, E. B., Ribeiro de Oliveira, M., Bonomi, P. D., Camidge, D. R., Chu, Q., Giaccone, G., Khaira, D., Ramalingam, S. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3090 · Cited by 564
Byers, L. A., Wang, J., Nilsson, M. B., Fujimoto, J., Saintigny, P., Yordy, J., Giri, U., Peyton, M., Fan, Y. H., Diao, L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0112 · Cited by 557
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Gardner, E. E., Lok, B. H., Schneeberger, V. E., Desmeules, P., Miles, L. A., Arnold, P. K., Ni, A., Khodos, I., de Stanchina, E., Nguyen, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.006 · Cited by 526
Lara, P. N., Natale, R., Crowley, J., Lenz, H. J., Redman, M. W., Carleton, J. E., Jett, J., Langer, C. J., Kuebler, J. P., Dakhil, S. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1061 · Cited by 525
Ott, P. A., Elez, E., Hiret, S., Kim, D.-W., Morosky, A., Saraf, S., Piperdi, B., & Mehnert, J. M. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.5069 · Cited by 521
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
Mohammad, H. P., Smitheman, K. N., Kamat, C. D., Soong, D., Federowicz, K. E., Van Aller, G. S., Schneck, J. L., Carson, J. D., Liu, Y., Butticello, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.06.002 · Cited by 504
Jackman, D. M., & Johnson, B. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67569-1 · Cited by 503
Ardizzoni, A., Hansen, H., Dombernowsky, P., Gamucci, T., Kaplan, S., Postmus, P., Giaccone, G., Schaefer, B., Wanders, J., & Verweij, J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2090 · Cited by 480
Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. Q., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0011 · Cited by 436
Pietanza, M. C., Waqar, S. N., Krug, L. M., Dowlati, A., Hann, C. L., Chiappori, A., Owonikoko, T. K., Woo, K. M., Cardnell, R. J., Fujimoto, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.77.7672 · Cited by 399
Fried, D. B., Morris, D. E., Poole, C., Rosenman, J. G., Halle, J. S., Detterbeck, F. C., Hensing, T. A., & Socinski, M. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.178 · Cited by 391
Nowell, C. S., & Radtke, F. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.145 · Cited by 369
von Pawel, J., Jotte, R., Spigel, D. R., O'Brien, M. E. R., Socinski, M. A., Mezger, J., Steins, M., Bosquée, L., Bubis, J., Nackaerts, K., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5392 · Cited by 352
VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
Evans, W. K., Shepherd, F. A., Feld, R., Osoba, D., Dang, P., & Deboer, G. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.11.1471 · Cited by 317
Aurora Kinase Inhibitors: Current Status and Outlook
Bavetsias, V., & Linardopoulos, S. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00278 · Cited by 277
Skarlos, D. V., Samantas, E., Kosmidis, P., Fountzilas, G., Angelidou, M., Palamidas, P. H., Mylonakis, N., Provata, A., Papadakis, E., Klouvas, G., et al. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058931 · Cited by 274
Histone Acetylation and Chromatin Remodeling
Gregory, P. D., Wagner, K., & Hörz, W. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5187 · Cited by 274
Slotman, B. J., Mauer, M. E., Bottomley, A., Faivre-Finn, C., Kramer, G. W. P. M., Rankin, E. M., Snee, M., Hatton, M., Postmus, P. E., Collette, L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0746 · Cited by 254
Approach to the Patient with Possible Cushing’s Syndrome
Boscaro, M., & Arnaldi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0612 · Cited by 251
Poirier, J. T., Gardner, E. E., Connis, N., Moreira, A. L., de Stanchina, E., Hann, C. L., & Rudin, C. M. (2015) · Oncogene · doi:10.1038/onc.2015.38 · Cited by 248
Management of Small Cell Lung Cancer
Simon, G. R., & Turrisi, A. (2007) · Chest · doi:10.1378/chest.07-1385 · Cited by 226
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
Fu, L.-L., Tian, M., Li, X., Li, J.-J., Huang, J., Ouyang, L., Zhang, Y., & Liu, B. (2015) · Oncotarget · doi:10.18632/oncotarget.3551 · Cited by 221
Gadgeel, S. M., Pennell, N. A., Fidler, M. J., Halmos, B., Bonomi, P., Stevenson, J., Schneider, B., Sukari, A., Ventimiglia, J., Chen, W., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.002 · Cited by 212
Umemura, S., Mimaki, S., Makinoshima, H., Tada, S., Ishii, G., Ohmatsu, H., Niho, S., Yoh, K., Matsumoto, S., Takahashi, A., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000250 · Cited by 200
Arnold, A. M., Seymour, L., Smylie, M., Ding, K., Ung, Y., Findlay, B., Lee, C. W., Djurfeldt, M., Whitehead, M., Ellis, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3083 · Cited by 196
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
Evans, W. K., Osoba, D., Feld, R. D., Shepherd, F. A., Bazos, M. J., & Deboer, G. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.1.65 · Cited by 192
Le Péchoux, C., Laplanche, A., Faivre-Finn, C., Ciuleanu, T., Wanders, R., Lerouge, D., Keus, R., Hatton, M., Videtic, G. M., Senan, S., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq576 · Cited by 190
Seute, T., Leffers, P., ten Velde, G. P. M., & Twijnstra, A. (2008) · Cancer · doi:10.1002/cncr.23361 · Cited by 188
Pietanza, M. C., Kadota, K., Huberman, K., Sima, C. S., Fiore, J. J., Sumner, D. K., Travis, W. D., Heguy, A., Ginsberg, M. S., Holodny, A. I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2059 · Cited by 188
De Ruysscher, D., Botterweck, A., Dirx, M., Pijls-Johannesma, M., Wanders, R., Hochstenbag, M., Dingemans, A.-M. C., Bootsma, G., Geraedts, W., Simons, J., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn559 · Cited by 186
Brock, M. V., Hooker, C. M., Syphard, J. E., Westra, W., Xu, L., Alberg, A. J., Mason, D., Baylin, S. B., Herman, J. G., Yung, R. C., et al. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.08.022 · Cited by 183
Owonikoko, T. K., Behera, M., Chen, Z., Bhimani, C., Curran, W. J., Khuri, F. R., & Ramalingam, S. S. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824c7f4b · Cited by 163
Pandya, K. J., Dahlberg, S. E., Hidalgo, M. M., Cohen, R. B., Lee, M. W., Schiller, J. H., & Johnson, D. H. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318155a439 · Cited by 141
Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes
Varghese, A. M., Zakowski, M. F., Yu, H. A., Won, H. H., Riely, G. J., Krug, L. M., Kris, M. G., Rekhtman, N., Ladanyi, M., Wang, L., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000142 · Cited by 141
Activity of docetaxel (Taxotere) in small cell lung cancer
Smyth, J. F., Smith, I. E., Sessa, C., Schöffski, P., Wanders, J., Franklin, H., & Kaye, S. B. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90455-3 · Cited by 139
Prognostic factors differ by tumor stage for small cell lung cancer
Foster, N. R., Mandrekar, S. J., Schild, S. E., Nelson, G. D., Rowland, K. M., Deming, R. L., Kozelsky, T. F., Marks, R. S., Jett, J. R., & Adjei, A. A. (2009) · Cancer · doi:10.1002/cncr.24314 · Cited by 128
Self-citationMasters, G. A., Declerck, L., Blanke, C. D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.130 · Cited by 125
Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
Horita, N., Yamamoto, M., Sato, T., Tsukahara, T., Nagakura, H., Tashiro, K., Shibata, Y., Watanabe, H., Nagai, K., Inoue, M., et al. (2015) · Scientific Reports · doi:10.1038/srep15437 · Cited by 107
Ross, J. S., Wang, K., Elkadi, O., Tarasen, A. J., Foulke, L., Sheehan, C. E., Otto, G. A., Palmer, G. A., Yelensky, R., Lipson, D., et al. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202447 · Cited by 105
Kalari, S. K., Jung, M., Kernstine, K. H., Takahashi, T., & Pfeifer, G. P. (2012) · Oncogene · doi:10.1038/onc.2012.362 · Cited by 92
Ectopic ACTH syndrome: Molecular bases and clinical heterogeneity
Terzolo, M., Reimondo, G., Alì, A., Bovio, S., Daffara, F., Paccotti, P., & Angeli, A. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s83 · Cited by 86
Calvo, E., Moreno, V., Flynn, M., Holgado, E., Olmedo, M. E., Criado, M. P. L., Kahatt, C. M., López-Vilariño, J. A., Siguero, M., Fernández‐Teruel, C., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx357 · Cited by 86
Hellmann, M. D., Ott, P. A., Zugazagoitia, J., Ready, N., Hann, C. L., de Braud, F., Antonia, S. J., Ascierto, P. A., Moreno, V., Atmaca, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.8503 · Cited by 84
Role of surgical resection for patients with limited disease-small cell lung cancer
Takenaka, T., Takenoyama, M., Inamasu, E., Yoshida, T., Toyokawa, G., Nosaki, K., Hirai, F., Yamaguchi, M., Shimokawa, M., Seto, T., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.01.010 · Cited by 82
Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.
Yamamoto, N., Tsurutani, J., Yoshimura, N., Asai, G., Moriyama, A., Nakagawa, K., Kudoh, S., Takada, M., Minato, Y., & Fukuoka, M. (2006) · PubMed · Cited by 79
Meriney, S. D., Hulsizer, S., Grinnell, A. D., & Lennon, V. A. (1996) · Annals of Neurology · doi:10.1002/ana.410400510 · Cited by 71
Sakre, N., Wildey, G. M., Behtaj, M., Kresak, A. M., Yang, M., Fu, P., & Dowlati, A. (2016) · Oncotarget · doi:10.18632/oncotarget.13362 · Cited by 64
Carbone, D. P., Morgensztern, D., Moulec, S. L., Santana-Dávila, R., Ready, N., Hann, C. L., Glisson, B. S., Dowlati, A., Rudin, C. M., Lally, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.8507 · Cited by 54
Small Cell Lung Cancer: Are We Making Progress?
Dowell, J. E., & Palmer, B. F. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181bccef5 · Cited by 51
Molina, J. R., Foster, N. R., Reungwetwattana, T., Nelson, G. D., Grainger, A. V., Steen, P. D., Stella, P. J., Marks, R. S., Wright, J., & Adjei, A. A. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.03.004 · Cited by 43
Self-citationMolecular profiling of small cell lung cancer in a Japanese cohort
Wakuda, K., Kenmotsu, H., Serizawa, M., Koh, Y., Isaka, M., Takahashi, S., Ono, A., Taira, T., Naito, T., Murakami, H., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.02.013 · Cited by 41
O’Carrigan, B., Miguel, M. J. D., Papadatos-Pastos, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.2504 · Cited by 35
Cho, D. C., Mahipal, A., Dowlati, A., Chow, W. A., Segal, N. H., Chung, K. Y., Schneider, B. J., Nemunaitis, J. J., Razak, A. R. A., Tsai, F. Y.-C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.8517 · Cited by 34
Gadgeel, S. M., Ventimiglia, J., Kalemkerian, G. P., Fidler, M. J., Chen, W., Sukari, A. W., Halmos, B., Boerner, J. L., Wozniak, A. J., Galasso, C., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.8504 · Cited by 26
Hellmann, M. D., Antonia, S. J., Ponce, S., Ott, P. A., Calvo, E., Taylor, M. H., Ready, N., Hann, C. L., de Braud, F., Eder, J. P., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.11.446 · Cited by 21
Farago, A. F., Drapkin, B. J., Charles, A., Yeap, B. Y., Heist, R. S., Azzoli, C. G., Jackman, D. M., Marcoux, J. P., Barbie, D. A., Myers, D. T., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.8571 · Cited by 9
Metadata
- Authors
- Wang, S., Zimmermann, S., Parikh, K., Mansfield, A. S., & Adjei, A. A.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 94
- Issue
- 8
- Pages
- 1599-1622
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2966817868
- Cited by
- 282
- References
- 84
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.